Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is the most common cause of dementia and most of AD patients suffer from vascular abnormalities and neuroinflammation. There is an urgent need to develop novel blood biomarkers capable of diagnosing Alzheimer’s disease (AD) at very early stage. This study was per...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung Eun, Lim, Do Sung, Cho, Yeong Hee, Choi, Kyu Yeong, Lee, Jang Jae, Kim, Byeong C., Lee, Kun Ho, Lee, Jung Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796542/
https://www.ncbi.nlm.nih.gov/pubmed/33422144
http://dx.doi.org/10.1186/s40364-020-00258-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796542/
https://www.ncbi.nlm.nih.gov/pubmed/33422144
http://dx.doi.org/10.1186/s40364-020-00258-5

Ejemplares similares